Dr. Michael I. Ghilezan
Overview
Michael Ghilezan is a Radiation Oncologist practicing medicine in Macomb, Michigan. He has been practicing medicine for over 38 years.
Dr. Ghilezan is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Non-Muscle Invasive Bladder Cancer, and Muscle Invasive Bladder Cancer.
Dr. Ghilezan is board certified in American Board Of Radiology. He is actively involved in clinical research, co-authoring 2 peer reviewed articles. Dr. Ghilezan is currently accepting new patients.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
17435 Hall Road, Macomb, MI 48044
4550 Investment Drive, Suite B111, Troy, MI 48098
70 Fulton Street, Pontiac, MI 48341
27900 Grand River Avenue, Suite 120, Farmington Hills, MI 48336
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Rose Cancer Treatment Center
Inga Grills is a Radiation Oncologist practicing medicine in Royal Oak, Michigan. She has been practicing medicine for over 27 years. Dr. Grills is highly rated in 41 conditions, according to our data. Her clinical expertise encompasses Arteriovenous Malformation, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Gamma Knife Radiosurgery. Dr. Grills is board certified in American Board Of Radiology. Dr. Grills is currently accepting new patients.
Rose Cancer Treatment Center
Prakash Chinnaiyan is a Radiation Oncologist practicing medicine in Royal Oak, Michigan. He has been practicing medicine for over 26 years. Dr. Chinnaiyan is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Brain Tumor, and Gamma Knife Radiosurgery. Dr. Chinnaiyan is board certified in American Board Of Radiology. Dr. Chinnaiyan is currently accepting new patients.
Henry Ford Cancer-Detroit
Mohamed Elshaikh is a Radiation Oncologist practicing medicine in Detroit, Michigan. Dr. Elshaikh is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Prostate Cancer, Cervical Cancer, Familial Prostate Cancer, and Lymphadenectomy.
Frequently Asked Questions about Dr. Michael I. Ghilezan
How do I make an appointment with Dr. Michael I. Ghilezan?
You can book an appointment with Dr. Michael I. Ghilezan by calling their office at 586-228-0299. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Michael I. Ghilezan a top-rated expert for Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michael I. Ghilezan is classified as an Advanced expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Michael I. Ghilezan specialize in?
While Dr. Michael I. Ghilezan is a Radiation Oncology, they have specific expertise in Prostate Cancer, Familial Prostate Cancer, and Non-Muscle Invasive Bladder Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.
Does Dr. Michael I. Ghilezan participate in research or clinical trials?
Yes. Dr. Michael I. Ghilezan has published 2 articles and abstracts on conditions like Prostate Cancer. You can view a list of Dr. Michael I. Ghilezan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Michael I. Ghilezan accept my insurance?
Dr. Michael I. Ghilezan accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 586-228-0299 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Familial Prostate CancerDr. Ghilezan isAdvanced. Learn about Familial Prostate Cancer.
- Prostate CancerDr. Ghilezan isAdvanced. Learn about Prostate Cancer.
- Experienced
- Muscle Invasive Bladder CancerDr. Ghilezan isExperienced. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerDr. Ghilezan isExperienced. Learn about Non-Muscle Invasive Bladder Cancer.